Literature DB >> 17451941

The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors.

P Konofaos1, K Kontzoglou, J Georgoulakis, T Megalopoulou, C Zoumpouli, Z Christoni, O Papadopoulos, G Kouraklis, P Karakitsos.   

Abstract

INTRODUCTION: The objective of the current study was to analyze the potential value of immunocytochemical analysis on ThinPrep (TP)-processed smears, from fine needle aspiration (FNA) biopsies, of breast tumors for the determination of ER and PR content as compared with the immunohistochemical analysis performed on paraffin-embedded breast tumor specimens. PATIENTS AND METHODS: Percutaneous FNA biopsy of focal breast lesions in 119 female adult patients during a 31-month period was performed. Subsequently, these patients underwent surgical resection of the tumors. ER and PR status of the tumors was determined by immunocytochemical analysis on TP-processed smears and by immunohistochemical studies in paraffin-embedded sections.
RESULTS: With the use of TP technique adequate material was observed in all cases. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and overall accuracy (OA) of the TP technique for the ER were 98.95%, 100%, 100%, 95.84% and 99.15% respectively. In addition, sensitivity, specificity, PPV, NPV and OA of the TP technique for the PR were 100%, 87.5%, 95.60%, 100% and 96.64%, respectively.
CONCLUSIONS: ER and PR status can be evaluated in FNA material from breast carcinomas by using the TP technique. Sample collection and storage is simple and permits the assortment of the FNA sample for both morphologic diagnosis and ancillary studies. The accuracy of TP technique in the detection of ER and PR content is comparable to those of the histological evaluation, and could be of paramount importance for the preoperative planning of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451941     DOI: 10.1016/j.suronc.2007.03.004

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  10 in total

1.  Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens.

Authors:  Rieko Nishimura; Kenjiro Aogi; Tamami Yamamoto; Daisuke Takabatake; Seiki Takashima; Norihiro Teramoto; Akihiro Kagawa; Sachiko Morita
Journal:  Virchows Arch       Date:  2010-12-21       Impact factor: 4.064

Review 2.  The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.

Authors:  Ian C Bennett; Apoorva Saboo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

3.  Fine-Needle Aspiration Cytology (FNAC) in Breast Cancer: A Reappraisal Based on Retrospective Review of 698 Cases.

Authors:  Mufaddal Kazi; Rajinder Parshad; V Seenu; Sandeep Mathur; K P Haresh
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

4.  Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors.

Authors:  Torill Sauer; Kristin Ebeltoft; Mette Kristin Pedersen; Rolf Kåresen
Journal:  Cytojournal       Date:  2010-12-31       Impact factor: 2.091

5.  Efficacy of liquid-based cytology versus conventional smears in FNA samples.

Authors:  Kalpalata Tripathy; Aparajita Misra; Joydip Kumar Ghosh
Journal:  J Cytol       Date:  2015 Jan-Mar       Impact factor: 1.000

6.  Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China.

Authors:  Zhihui Zhang; Peng Yuan; Huiqin Guo; Linlin Zhao; Jianming Ying; Mingrong Wang; Huan Zhao; Qinjing Pan; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

7.  Fine-needle aspiration cytology can play a role in neoadjuvant chemotherapy in operable breast cancer.

Authors:  Christian Garbar; Hervé Curé
Journal:  ISRN Oncol       Date:  2013-07-10

8.  HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimens.

Authors:  Rieko Nishimura; Nami Okamoto; Masakazu Satou; Kenta Kojima; Shinichi Tanaka
Journal:  Diagn Cytopathol       Date:  2016-01-22       Impact factor: 1.582

9.  Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections.

Authors:  Rieko Nishimura; Nami Okamoto; Masakazu Satou; Kenta Kojima; Shinichi Tanaka; Natsumi Yamashita
Journal:  Breast Cancer       Date:  2016-01-08       Impact factor: 4.239

Review 10.  Fine-needle aspiration and core biopsy in the diagnosis of breast lesions: A comparison and review of the literature.

Authors:  Suvradeep Mitra; Pranab Dey
Journal:  Cytojournal       Date:  2016-08-31       Impact factor: 2.091

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.